文献速递腹部MR

钆塞酸增强MRI定量评估肝功能:肝细胞摄取率

Quantitative Assessment of Liver Function by Using Gadoxetic Acid-enhanced MRI: Hepatocyte Uptake Ratio.
PubMed 文献 · Radiology · 2018-10-30

研究纳入50例慢性肝病或肝硬化参与者,在3.0 T MRI上行T1 mapping和弹性成像,以吲哚菁绿15分钟滞留率(ICG R15)为参考,评估肝细胞摄取率等参数与肝功能的关系。肝细胞摄取率与ICG R15呈负相关(r=-0.78,P<.001),识别ICG R15>20%的AUC为0.96,优于肝体积(AUC 0.70,P=.01)。

要点

  • 肝细胞摄取率与ICG R15呈负相关(r=-0.78,P<.001)。
  • 识别ICG R15>20%(肝切除禁忌)的AUC为0.96,优于肝体积0.70(P=.01)。
  • 慢性肝病或Child-Pugh A级中,ICG R15≤20%者肝细胞摄取率高于>20%者(P<.001)。

核心结论

  • 肝细胞摄取率与吲哚菁绿滞留试验所测肝功能呈负相关,对识别大范围肝切除禁忌者具有可接受的诊断效能。

研究设计与样本

  • 2016年8月至2016年10月纳入50例慢性肝病或肝硬化参与者,行3.0 T肝脏MRI(T1 mapping及弹性成像),以ICG R15为肝功能定量参考标准。

关键影像表现/征象

  • T1 maps采用Look-Locker序列,在钆塞酸给药(0.025 mmol/kg)前及给药后10分钟采集。
  • 肝细胞摄取率代表仅被肝细胞摄取的对比剂剂量。
  • 同时评估肝T1值(增强前后)、肝体积及胆总管强化程度等MRI参数。

诊断标准与关键数值

  • 肝细胞摄取率与ICG R15负相关,r=-0.78(P<.001)。
  • 识别ICG R15>20%(肝切除禁忌)的AUC为0.96,肝体积AUC为0.70(P=.01)。
  • 慢性肝病或Child-Pugh A级中,ICG R15≤20%者肝细胞摄取率高于ICG R15>20%者(P<.001)。

临床应用与阅片要点

  • 作者结论认为肝细胞摄取率对识别大范围肝切除禁忌者具有可接受的诊断效能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To determine whether hepatocyte uptake ratios derived at gadoxetic acid-enhanced MRI correlate with quantitative measures of liver function and can help to identify contraindication to major hepatectomy. Materials and Methods Between August 2016 and October 2016, 50 study participants with chronic liver disease or cirrhosis underwent liver MRI at 3.0 T including T1 mapping and elastography. Liver function was quantitatively assessed by using the indocyanine green retention test (ICG R15). T1 maps were obtained by using the Look-Locker sequence before and 10 minutes after gadoxetic acid administration (0.025 mmol/kg). The relationship between ICG R15 and the following MRI parameters was evaluated: pre- and postcontrast T1 values of the liver, hepatocyte uptake ratio representing the amount of contrast media solely taken into hepatocytes, liver volume, and degree of enhancement at the common bile duct. Diagnostic performance of the hepatocyte uptake ratio to identify patients with ICG R15 greater than 20% (ie, contraindication to hepatectomy) was compared with other parameters by using areas under the receiver operating characteristic curve. Results Hepatocyte uptake ratio showed a negative correlation with ICG R15 r of -0.78 (P < .001). In participants with chronic liver disease or Child-Pugh class A, those with ICG R15 of 20% or less showed higher hepatocyte uptake ratio than those with ICG R15 greater than 20% (P < .001). Hepatocyte uptake ratios demonstrated better performance for helping to detect ICG R15 greater than 20% than did liver volume (area under the curve, 0.96 vs 0.70; P = .01). Conclusion Hepatocyte uptake ratios are negatively correlated with liver function as measured by indocyanine green retention test and provide acceptable diagnostic performance for helping to identify participants who have contraindications to major hepatectomy. © RSNA, 2018 Online supplemental material is available for this article. See also the editorial by Reeder in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Yoon JH, Lee JM, Kang HJ, et al. Quantitative Assessment of Liver Function by Using Gadoxetic Acid-enhanced MRI: Hepatocyte Uptake Ratio. Radiology. 2018. PMID: 30375932. doi:10.1148/radiol.2018180753

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。